Research output

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

Associated organisations

    Research areas

  • Non-small cell lung cancer, Individualized radiotherapy, Concurrent chemotherapy radiotherapy, Phase II trial, Prospective, NORMAL TISSUE CONSTRAINTS, LOCALLY ADVANCED HEAD, LONG-TERM SURVIVAL, RADIATION-THERAPY, PHASE-III, DOSE-ESCALATION, RADIOTHERAPY, CHEMOTHERAPY, TRIAL, CISPLATIN
View graph of relations


Original languageEnglish
Pages (from-to)141-146
Number of pages6
JournalRadiotherapy and Oncology
Publication statusPublished - Jun 2019